This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n4http://linked.opendata.cz/resource/drugbank/drug/DB04707/identifier/bindingdb/
n2http://linked.opendata.cz/resource/drugbank/drug/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04707/identifier/pubchem-compound/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04707/identifier/pubchem-substance/
n15http://linked.opendata.cz/resource/drugbank/drug/DB04707/identifier/drugbank/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB04707/identifier/chemspider/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB04707/identifier/pdb/

Statements

Subject Item
n2:DB04707
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n12:DB04707 n13:DB04707
dcterms:title
HYDROXYFASUDIL
adms:identifier
n4:14031 n8:46508609 n9:HFS n10:3064778 n14:2325236 n15:DB04707
n5:IUPAC-Name
n6:271B4BB0-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4BB6-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4BB5-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4BB2-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4BB3-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4BB4-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4BAE-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4BAC-363D-11E5-9242-09173F13E4C5 n6:271B4BAF-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4BAD-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4BBC-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4BBD-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4BB7-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4BB8-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4BBA-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4BB9-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4BBB-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4BC2-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4BC4-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4BC5-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4BC1-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4BC0-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4BC3-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4BB1-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4BBE-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4BBF-363D-11E5-9242-09173F13E4C5